Short-course antibiotics for prosthetic joint infections treated with prosthesis retention

Clinical Microbiology and Infection

Volumn 18, Issue 11, 2012, Pages 1143-1148

  Puhto, A P ^a   Puhto, T ^a   Syrjala, H ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antibiotic treatment duration; Antimicrobial treatment; Orthopaedic implant infection; Prosthetic joint infection; Total joint arthroplasty

Indexed keywords

ANTIBIOTIC AGENT;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTHESIS; PROSTHESIS INFECTION; PROSTHESIS MATERIAL; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT DURATION;

EID: 84867617807     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03693.x     Document Type: Article

References (21)

1. Leone S, Borrè S, Monforte AD et al. Consensus document on controversial issues in the diagnosis and treatment of prosthetic joint infections. Int J Infect Dis 2010; 14 (suppl 4): 67-77.
2. Phillips JE, Crane TP, Noy M, Elliott TSJ, Grimer RJ. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br 2006; 88: 943-948.
3. Betsch BY, Eggli S, Siebenrock KA, Täuber MG, Mühlemann K. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis 2008; 46: 1221-1226.
4. Cobo J, Miguel LGS, Euba G et al. Early prosthetic joint infection: outcomes with debridement and implant retention followed by antibiotic therapy. Clin Microbiol Infect 2010; 17: 1632-1637.
5. Marculescu C, Cantey J. Polymicrobial prosthetic joint infections: risk factors and outcome. Clin Orthop Relat Res 2008; 466: 1397-1404.
6. Fisman DN, Reilly DT, Karchmer AW, Goldie SJ. Clinical effectiveness and cost-effectiveness of two management strategies for infected total hip arthroplasty in the elderly. Clin Infect Dis 2001; 32: 419-430.
7. Pulcini C, Couadau T, Bernard E et al. Adverse effects of parenteral antimicrobial therapy for chronic bone infections. Eur J Clin Microbiol Infect Dis 2008; 27: 1227-1232.
8. Meropol SB, Chan KA, Chen Z et al. Adverse events associated with prolonged antibiotic use. Pharmacoepidem Drug Saf 2008; 17: 523-532.
9. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-1654.
10. Zimmerli W, Ochsner PE. Management of infection associated with prosthetic joints. Infection 2003; 31: 99-108.
11. Zimmerli W. Prosthetic joint infection: diagnosis and treatment. Curr Infect Dis Rep 2000; 2: 377-379.
12. Berdal J, Skråmm I, Mowinckel P, Gulbrandsen P, Bjørnholt JV. Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections. Clin Microbiol Infect 2005; 11: 843-845.
13. Bernard L, Legout L, Zürcher-Pfund L et al. Six weeks of antibiotic treatment is sufficient following surgery for septic arthroplasty. J Infect 2010; 6: 125-132.
14. Martinez-Pastor JC, Munoz-Mahamud E, Vilchez F et al. Outcome of acute prosthetic joint infections due to gram-negative bacilli treated with open debridement and retention of the prosthesis. Antimicrob Agents Chemother 2009; 53: 4772-4777.
15. Soriano A, García S, Bori G et al. Treatment of acute post-surgical infection of joint arthroplasty. Clin Microbiol Infect 2006; 12: 930-933.
16. Vilchez F, Martínez-Pastor JC, García-Ramiro S et al. Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement. Clin Microbiol Infect 2011; 17: 439-444.
17. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. For the Foreign-Body Infection (FBI) Study Group. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections. J Am Med Assoc 1998; 279: 1537-1541.
18. McPherson EJ, Woodson C, Holtom P et al. Periprosthetic total hip infection: outcomes using a staging system. Clin Orthop Relat Res 2002; 403: 8-15.
19. McPherson EJ, Tontz W Jr, Patzakis M et al. Outcome of infected total knee utilizing a staging system for prosthetic joint infection. Am J Orthop (Belle Mead NJ) 1999; 28: 161-165.
20. Byren I, Bejon P, Atkins BL et al. One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 2009; 63: 1264-1271.
21. Giulieri SG, Graber P, Ochsner PE, Zimmerli W. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004; 32: 222-228.